Kirk Tanner

Company: National Brain Tumor Society

Job title: Senior Vice President

Seminars:

Panel Discussion: How Deal Making & Investment is Changing the Future Landscape for GBM 9:00 am

Setting the bar/considerations/criteria for investing or partnering Analyzing what level of strategic alignment is necessary Assessing preclinical models for investment/partnership appeal Reviewing public markets vs Private markets Exploring how to generate sufficient data to move to collaboration/investment? Discussing which mechanisms/targets are appealing or up-and-comingRead more

day: Conference Day 2

Panel Discussion: Overviewing & Investigating Success Stories of Crossing the BBB: What are the Mechanisms of Penetration & How Does this Effect Drug Efficacy? 11:30 am

Discussing new technologies emerging that manipulate the BBB to deliver therapeutic agents directly to the tumor site Recounting case studies of success stories in crossing the BBB – how can this be applied? Examining the standard differences in delivery between the US and EuropeRead more

day: Conference Day 2

Panel Discussion: Addressing the Peaks & Troughs of the GBM Space: What is Promising & Where is Innovation Necessary? 9:00 am

Highlighting emerging therapies such as immunotherapy and personalized medicine showing potential in GBM treatment Discussing barriers such as the blood-brain barrier, tumor resistance, and high recurrence rates Exploring key areas for innovation, including diagnostics, drug delivery, and combination therapiesRead more

day: Conference Day 1